The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection

Nature Medicine

Volumn 6, Issue 5, 2000, Pages 549-555

  Wang, Hao ^a,b,c   DeVries, Mark E ^b,c   Deng, Shaoping ^a,b   Khandaker, Masud H ^b,c   Pickering, J Geoff ^c   Chow, Larry H ^c   Garcia, Bertha ^c   Kelvin, David J ^a,b   Zhong, Robert ^a,b,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; CYTOKINE RELEASE; FIBRIN DEPOSITION; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; TRANSGENIC ANIMAL; XENOGRAFT;

ACUTE DISEASE; ANIMALS; ANTIBODIES; B-LYMPHOCYTES; BLOOD VESSELS; CORONARY VESSELS; CRICETINAE; GRAFT REJECTION; GRAFT SURVIVAL; GUINEA PIGS; HEART TRANSPLANTATION; INTERFERON TYPE II; INTERLEUKIN-12; KIDNEY TRANSPLANTATION; LYMPHOPENIA; MESOCRICETUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RATS; RATS, INBRED LEW; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA;

EID: 0034026723     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/75029     Document Type: Article

References (39)

1. Auchincloss, H.J. & Sachs, D.H. Xenogeneic transplantation. Annu. Rev. Immunol. 16, 433-470 (1998).
2. van den Bogaerde, J. & White, D.J. Xenogeneic transplantation. Br. Med. Bull. 53, 904-920 (1997).
3. Leventhal, J.R., et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 56, 1-8 (1993).
4. Zaidi, A. et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65, 1584-1590 (1998).
5. Lin, S.S. et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J. Clin. Invest. 101, 1745-1756 (1998).
6. Xu, H. et al. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. J. Thorac. Cardiovasc. Surg. 115, 1342-1349 (1998).
7. Platt, J.L. et al. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation 52, 1037-1043 (1991).
8. Blakely, M.L. et al. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58, 1059-1066 (1994).
9. Candinas, D. et al. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. Transplantation 62, 1920-1927 (1996).
10. Matsumiya, G. et al. Analysis of rejection mechanism in the rat to mouse cardiac xenotransplantation. Role and characteristics of anti-endothelial cell antibodies. Transplantation 57, 1653-1660 (1994).
11. Heinzel, F.P., Sadick, M.D., Holaday, B.J., Coffman, R.L. & Locksley, R.M. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59-72 (1989).
12. Sayegh, M.H. et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181, 1869-1874 (1995).
13. Nickerson, P. et al. Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation 63, 489-494 (1997).
14. Takeuchi, T., Lowry, R.P. & Konieczny, B. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 53, 1281-1294 (1992).
15. Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276 (1995).
16. Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423-426 (1991).
17. Lauwerys, B.R., Renauld, J.C. & Houssiau, F.A. Inhibition of in vitro immunoglobulin production by IL-12 in murine chronic graft-vs.-host disease: synergism with IL-18. Eur. J. Immunol 28, 2017-2024 (1998).
18. Morris, S.C. et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152, 1047-1056 (1994).
19. Yoshimoto, T., Okamura, H., Tagawa, Y.I., Iwakura, Y. & Nakanishi, K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc. Natl. Acad. Sci. USA 94, 3948-3953 (1997).
20. Abed, N.S., Chace, J.H., Fleming, A.L. & Cowdery, J.S. Interferon-gamma regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-gamma-mediated inhibition of B cell differentiation. Cell Immunol. 153, 356-366 (1994).
21. Wang, H., et al. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model. Transplantation 68, 1643-1651 (1999).
22. Zhang, Z. et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 62, 1267-1272 (1996).
23. Piccotti, J.R. et al. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J. Immunol. 157, 1951-1957 (1996).
24. Piccotti, J.R. et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. J. Immunol 160, 1132-1138 (1998).
25. Murphy, B., Auchincloss, H.J., Carpenter, C.B. & Sayegh, M.H. T cell recognition of xeno-MHC peptides during concordant xenograft rejection. Transplantation 61, 1133-1137 (1996).
26. Konieczny, B.T. et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 160, 2059-2064 (1998).
27. Markees, T.G. et al. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-γ, and CTLA4. J. Clin. Invest. 101, 2446-2455 (1998).
28. Sypek, J.P. et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802 (1993).
29. Yoshida, A., Koide, Y., Uchijima, M. & Yoshida, T.O. IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem. Biophys. Res. Commun. 198, 857-861 (1994).
30. Waterworth, P.D. et al. Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy. Transplant. Proc. 29, 899-900 (1997).
31. Bhatti, F.N. et al. Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant. Proc. 31, 958(1999).
32. Zaidi, A. et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65, 1584-1590 (1998).
33. Hutchinson, I.V., Pravica, V., Perrey, C. & Sinnott, P. Cytokine gene polymorphisms and relevance to forms of rejection. Transplant. Proc. 31, 734-736 (1999).
34. Turner, D. et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 64, 776-779 (1997).
35. Dalton, D.K. et al. Multiple defects of immune cell function in mice with disrupted Interferon gamma genes. Science 259, 1739-1742 (1993).
36. Noben-Trauth, N., Kropf, P. & Muller, I. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271, 987-990 (1996).
37. Magram, J. et al. IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity 4, 471-481 (1996).
38. Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423-426 (1991).
39. Corry, R.J., Winn, H.J. & Russell, P.S. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16, 343-350 (1973).